Background and Purpose-The aim of this study was to establish the difference in burden of cerebrovascular disease across the different health regions of the United Kingdom and to determine whether the initial management of new cases of stroke and transient ischemic attack (TIA) was uniform across the United Kingdom. Methods-The General Practice Research Database (GPRD) is a national database used for epidemiological studies. This was a cohort study identifying incident cases of stroke and TIA over a 5-year study period between 1992 and 1996. The population studied was patients registered with general practitioners contributing to the GPRD across the different health regions of the United Kingdom. Outcome measures were new diagnoses of stroke and TIA, new prescriptions for antiplatelet and anticoagulant agents, and referrals made for specialist opinion. Results-The age-adjusted annual incidence rate across all regions was 151 per 100 000 for stroke and 190 per 100 000 for TIA. There was almost a 2-fold difference in the incidence of cerebrovascular disease between the regions. The management of stroke and TIA in terms of antiplatelet prescription and of referral onward for further opinion to hospital specialists varied significantly between regions. Conclusions-Reported stroke and TIA incidence on the GPRD was comparable to that of other European studies. There were striking regional differences in the incidence of disease. The primary care management, both in prescription and referral rates, varied significantly between the different regions. There was a marked underuse of antiplatelet and anticoagulant agents, and referral rates for specialists' opinions were low. 
S
troke is a common cause of morbidity and mortality in developed countries, 1 with 100 000 new cases of stroke per year in England and Wales. 2 Emphasis has been placed on strategies for prevention by medical and surgical interventions. 3 Both primary and secondary preventative strategies consume healthcare resources, and it has been suggested that there is unmet need in the provision of services, particularly for the surgical procedure of carotid endarterectomy. 4 For an equitable allocation of resources to occur, the geographical variation in burden of disease must be taken into account. The initial management of transient ischemic attack (TIA) and ischemic stroke is essential in the secondary prevention of further stroke, and trends in prescribing and referral are indicators of how cerebrovascular disease is dealt with in the primary care setting.
The General Practitioner Research Database (GPRD) is a UK database that has been used in primary care epidemiological studies 5 and is recognized as a potentially useful source of national morbidity data. 6 All patients in the care of a participating general practitioner (GP) are automatically registered onto the GPRD. Participating GPs enter clinical information, including significant diagnoses and subsequent interventions, such as prescriptions and referrals. Patients diagnosed and managed at home are recorded; a validation carried out in 1991 suggested that 87% of patients seen in the hospital had their diagnoses recorded on the database. 7 Thus, the completeness of recording is high. We used this database to investigate the frequency of diagnosis of cerebrovascular disease as perceived by GPs and to determine whether the initial management of stroke and TIA was uniform across the different Regional Health Authorities (RHAs) of the United Kingdom. This work obtained the necessary approval of the Scientific and Ethics Advisory Group of the Office for National Statistics.
Subjects and Methods
Data for patients with new cases of stroke and TIA presenting to GPs were retrieved from the GPRD by using appropriate diagnostic codes (see Table 1 ). Diagnostic codes are entered onto the database by using the Oxford medical information system (OXMIS) codes. This coding system is derived from the eighth revision of the International Classification of Diseases. The OXMIS codes are designed to be all-encompassing, giving a wide choice of codes for the same condition to ensure that a code matching the GP's diagnosis is available. The database contains complete information on age, sex, and prescribing data. There are incomplete data on weight, blood pressure, and smoking habits and on diagnostic tests, whereas a record of hospitalization is an administrative procedure that is well recorded.
The study period ran for 5 consecutive years between 1992 and 1996. Patients with a diagnosis of stroke or TIA from preceding years were excluded to ensure that only new subject data were retrieved for analysis. Prescriptions for antiplatelet or anticoagulant agents were analyzed, and all strengths from the minimum to the maximum were included. The antiplatelet agents that were searched for were aspirin (all strengths from 30 to 648 mg) and dipyridamole (25 to 100 mg), and the anticoagulant agents that were searched for were warfarin (1 to 5 mg), nicoumalone (1 to 4 mg), and phenindione (10 to 50 mg). Any referrals made for specialists' opinions within 7 days of the new diagnostic code entry were analyzed.
Statistical analyses were undertaken by use of Stata (StataCorp, 1999) and SAS version 6 (SAS Institute, 1989). The crude incidence data for each region was standardized by 5-year age group for the UK population in 1996. Correlations between regional rates of incidence, referral, and antiplatelet prescription was measured by Kendall -a, with 95% confidence limits 8 and continuity-corrected probability values.
Sixty case notes with a diagnostic code for TIA (30 cases) and stroke (30 cases) for patients who had been referred for specialists' opinions were obtained randomly and anonymously from participating practices. Depersonalized copies of all correspondence from the specialist to whom the patient had been referred were examined. The diagnosis made by the specialist was compared with the diagnostic code entered onto the GPRD by the GP to determine how often they were in agreement, as a test of the validity of the diagnostic data entered onto the GPRD (see Table 2 ).
Results
The GPRD had a mean population of 2 442 911 between 1992 and 1996, and we retrieved information on 17 404 patients with a new diagnosis of stroke and 22 195 patients with a new diagnosis of TIA.
Crude mean annual stroke incidence per 100 000 was 143, age-adjusted to 151 for the UK population of 1996. Crude TIA incidence was 182, age-adjusted to 190. The incidence of both TIA and stroke varied between the different health regions (see Table 3 ). The 2 test was used to test for differences in incidence of stroke and TIA between the RHAs. Differences between RHAs in stroke incidence were statistically significant when pooled between years and also for each year (PϽ0.00005 in all cases). Statistically significant differences in the incidence of TIA for the pooled years and for each individual year were also observed between the RHAs (PϽ0.00005 in all cases). Yorkshire had the highest incidence, at 194 (stroke) and 249 (TIA) per 100 000 of the population, compared with 115 and 122 per 100 000 for Oxford, the region with the lowest incidence.
Prescription rates for antiplatelet agents varied significantly between the RHAs for both TIA and stroke patients. Antiplatelets were prescribed for 15% to 25% of the stroke patients and for 30% to 45% of the TIA patients over the 5 Diagnosis made by specialist (SP) was compared with diagnostic code entered onto the GPRD by the GP. N indicates number of patients with diagnostic code provided by GP; n, number of patients with diagnosis by SP.
years, depending on region (see Figure 1 ). Over time, the prescription of antiplatelets fluctuated Ϸ37.5% for TIA and 17% for stroke. Prescription rates for anticoagulants were 1.26% (95% CI 0.97% to 1.47%) for stroke and 1.04% (95% CI 0.72% to 1.56%) for TIA for the time period.
The variation in referral rates between RHAs was statistically significant; they were pooled over all years and within each year from 1992 to 1996 and included both stroke and TIA. Referral rates varied from 14% (Yorkshire) to 26% (Oxford) for TIA, with a mean of 18.8% over the 5-year period for all regions. For stroke, referral rates varied more strikingly between RHAs, from 30% in Yorkshire to 56% in Scotland, with a mean of 39% (see Figure 2) .
We hypothesized that the referral rate would be related to the local incidence of disease; if the regional incidence was high, there would be greater expertise in managing stroke and TIA among GPs, resulting from increased experience and, possibly, more accessible referral pathways to secondary stroke care. The correlation between incidence and referral rates was examined. These were nonsignificant for stroke (Kendall -aϭϪ0.25, 95% CI Ϫ0.64 to 0.25; Pϭ0.1740) and for TIA (Kendall -aϭϪ0.35, 95% CI Ϫ0.69 to 0.11; 
Pϭ0.0529).
The correlation between referral rate and antiplatelet prescription rate was also examined to determine whether GPs were prescribing initial drug therapy as the sole modality of treatment and not referring the patient onward. These are nonsignificant for stroke (Kendall -aϭϪ0.28, 95% CI Ϫ0.66 to 0.21; Pϭ0.1275) and for TIA (Kendall -aϭϪ0.10, 95% CI Ϫ0.51 to 0.34; Pϭ0.5923).
To validate the GP diagnostic coding, 60 patient records were obtained. Eight records had insufficient information and were excluded. For the 27 patients referred with a diagnostic code for TIA, the GP and specialist concurred exactly in 13 cases (48%), and a diagnosis of stroke rather than TIA was made by the specialist in a further 5 cases (18%). This gave an overall agreement in opinion of cerebrovascular diagnosis of 66%. For the 25 referrals with a diagnostic code for stroke, there was a concurrence of opinion in exactly in 16 cases (64%), and a diagnosis of TIA rather than stroke was made in a further 4 cases (16%), giving an overall agreement in opinion of cerebrovascular diagnosis of 80%.
Discussion
The mean annual incidence of stroke was 151 per 100 000 within this national database over the 5-year study period, and there was a significant variance in reporting of new cases of cerebrovascular disease between the different health regions.
The incidence data from the GPRD for stroke is comparable to figures reported from European stroke registers. Incidence rates of stroke reported range from 111 per 100 000 from Warsaw, 9 145 per 100 000 from Tilburg, the Netherlands, 10 and 155 per 100 000 from Umbria 11 up to 170 per 100 000 from Belluno, Italy, 12 and 221 per 100 000 from Innherred, Norway. 13 The Oxfordshire Community Stroke Project reported a crude incidence rate of 160 per 100 000 adjusted to 200 per 100 000. 14 Reporting of new cases of stroke to the GPRD in the Oxford region gave a crude incidence rate of 95 per 100 000, adjusted to 131 per 100 000 for the 1996 population. Direct comparison is not possible; the populations sampled were different, study methodology was different, and the studies are a decade apart. Nonetheless, comparing the incidence rates from different studies of very similar populations raises the issue of the validity of the data reported to the GPRD.
There are a number of methodological difficulties in using a very large database covering a wide geographical area. The first problem is the definition of stroke for selecting subjects for inclusion in the study. Most studies use the World Health Organization definition of stroke, 15 but that was not possible in the present study. Instead, we relied on the OXMIS coding system, which is designed to ensure that participating GPs are able to match their own diagnosis with an appropriate code. The aim of this system is to ensure that cases are not missed, although the specificity of a single definition is lost. Moreover, we included only those codes appropriate for ischemic stroke. Most studies include subarachnoid and intracerebral hemorrhages in their figures, but we felt that the inclusion of codes for headache and meningism would lead to an unacceptable overestimation of stroke incidence.
True incident cases must be first-ever strokes. Attention was paid to the issue of case ascertainment in the methodology. To minimize the possibility of counting recurrent strokes, once a diagnostic code for stroke or TIA was entered, that patient was subsequently excluded for the rest of the study period. In addition, any patient with a diagnostic code for cerebrovascular disease from the inception of the GPRD in 1987 and before the study start date was also excluded. It is possible that patients could potentially have had strokes before the start of the database, and if that diagnosis had not been entered, then a recurrent stroke would be counted as a first-ever stroke. However, contributing GPs would be expected to enter major clinical events such as stroke in a retrospective as well as contemporaneous fashion, but these data are not completely reliable. Thus, although we were able to reliably count first strokes since the start of the study, it is possible that these were not first-in-a-lifetime strokes, the criterion for incident cases.
Community-based studies are more accurate than are hospital-based studies because the rates of hospital admission for stroke vary on the basis of both location and time. 16 This is even more relevant in the case of TIA and minor stroke, which can be managed in the community. The GPRD captured all patients presenting either primarily to the GP or secondarily on discharge from hospital back to the care of the GP. If patients bypassed the GP by presenting to the hospital directly, the diagnostic code would be entered subsequently, on receiving the hospital discharge summary. If patients were admitted to the hospital and subsequently died, they were removed from the doctor's list, and the cause of death was usually recorded on the database. Hence, the GP data are the most complete data available from routine sources of new events because these data include patients with episodes that are diagnosed and managed in the community as well as patients that are seen in the hospital.
Both the size and the nature of the population studied influence estimates of disease incidence. 17 The population of the GPRD increased year on year, from 1 816 068 in 1992 to 2 685 432 in 1996. In general terms, the larger the population studied, the greater is the number of incident cases that will occur, and the narrower are the CIs. The nature of the population studied is important; studies of older populations will report higher incidences than will studies of the general population. The GPRD population consists of people registered with participating practices and, as such, should be representative of the population at large.
The mean annual incidence of TIA reported over the 5-year study period was 190 per 100 000. There are fewer reports of TIA incidence compared with stroke incidence in the literature. Studies attempting to measure incidence rates for TIA in different populations report widely differing rates, and this again depends on the methodology used. One of the difficulties in accurately estimating the incidence of TIA is the transitory nature of the symptoms, which makes patients less likely to seek medical advice. 18 Therefore, studies relying on case ascertainment through routine medical sources such as general practice and hospital records may be underestimating TIA rates. In an attempt to address this point, several studies have used survey methodologies with direct questions on symptomatology. Prospective registry-type studies with stringent inclusion criteria tend to report lower incidences, rang-ing from 50 per 100 000 19 to 80 per 100 000, 20, 21 whereas studies relying on survey methodologies report higher incidence rates, ranging from 280 per 100 000 22 to 310 per 100 000. 23 It may be that the true incidence of TIA is likely to lie somewhere between the high incidence reported by subjects in the community when directly questioned and the low incidence reported by prospective observational studies.
The higher reported incidence of TIA compared with stroke has several possible explanations. The clinical diagnosis of TIA is recognized to be difficult, with poor interobserver agreement, 24 and the distinction between stroke and TIA is dependent on time. If the diagnostic code of TIA is entered onto the GPRD, it is possible that the symptoms could persist for Ͼ24 hours without the GP being aware of the fact, which would lead to an underestimation of stroke and an overestimation of TIA. Although there is the facility for entry codes to be altered subsequently, this would not necessarily happen. In the present study, reported TIA rates were uniformly higher than stroke rates, possibly reflecting this methodological problem. The case notes that were examined to verify the accuracy of diagnosis made by study GPs confirm this problem. Diagnostic agreement between the study GPs and the specialists to whom the stroke patients were referred reached 64%. A further 16% of patients initially diagnosed with stroke by the GP were subsequently given the diagnosis of TIA by the specialist, presumably with the additional benefit of time. The same pattern was repeated for patients given a diagnostic code for TIA by the GP, with 18% of these cases subsequently diagnosed as stroke by the specialist. The validation exercise also illustrates the difficulty in obtaining accurate diagnoses of TIAs by GPs. The agreement in diagnosis between study GPs and specialists reached only 48%, and in a further 33% of cases, the final diagnoses reached by the specialists were not even cerebrovascular in etiology (see Table 2 ).
Antiplatelet agents are recognized prophylaxes for patients with TIA and stroke in the prevention of further adverse vascular events, 25 and there is an overall risk reduction of 4.3% in patients who are prescribed aspirin for previous stroke or TIA. 26 Despite this, there is some evidence that there is suboptimal secondary prevention in patients suffering from stroke 27 as well as other vascular diseases 28 in the United Kingdom. Data for GP prescription of antiplatelets in the present study suggest that these agents are markedly underused in the secondary prevention of stroke in the United Kingdom, with prescribing rates of 37% for TIA and 17% for stroke. The variation in prescribing rates across the regions shows that even this suboptimal management is not uniform between the regions. The low overall prescription rates could partially be explained by the study methodology. Only new prescriptions issued within 7 days of first consultation and entry of diagnostic code were counted. This would have excluded patients already on antiplatelet agents for coexisting conditions and also patients returning from the hospital who had already been issued a prescription. Nonprescription aspirin obtained from the chemist would not be recorded on the database, and this would particularly affect the group aged Ͻ60 years, for whom the GPs might try to avoid prescription charges. Nonetheless, this does not explain regional differences in prescribing over the study period; the possible underestimate of prescribing would apply uniformly to all regions.
Adjusted-dose warfarin is also recognized as being useful in the prevention of stroke in patients with nonvalvular atrial fibrillation. The prescribing rates for anticoagulants were low: 1.26% for stroke and 1.04% for TIA. Although the diagnostic codes are not specific for cardioembolic events secondary to atrial fibrillation, it could be reasonably expected that Ϸ5% of the subjects had suffered this type of event, on the basis of the prevalence of atrial fibrillation in the UK population. Previous studies have found that anticoagulants are underused in the management of atrial fibrillation, 29 and these data support this observation.
Referral rates for further opinion were higher for stroke patients (39%) than for TIA patients (18.8%). A proportion of these patients would have returned to the care of the GP from the hospital setting and would, thus, have not required referral, leading to an underestimate of patients being dually managed. However, there was again a marked difference across the regions for both TIA and stroke. One hypothesis to explain this observation is that the prescription of prophylaxis in the form of antiplatelets would constitute the totality of treatment, and further investigation or opinion would be unnecessary. However, there was no significant correlation found between regions with high prescribing rates and low referral rates.
In terms of the relationship between disease incidence and the rate of referral, generally, the regions with higher incidence rates had the lower referral rates (ie, the Yorkshire region). This tendency suggests either that health care rationing for stroke patients is occurring or that GPs who are exposed to greater numbers of patients presenting with stroke and TIA feel concomitantly more confident in dealing with them alone. The referral rates suggest that too few patients with a new diagnosis of cerebrovascular disease are being appropriately referred onward for further evaluation and management. There was a significant variation in referral across the different regions, and access to a specialist's opinion would appear to be partially dependent on location. Taken in conjunction with the low prescribing rates, these data suggest that greater educational input is required to improve the secondary prevention of stroke and to refer greater numbers of these patients for specialists' opinions in the United Kingdom.
